2 Beaten-Down Healthcare Stocks That Could Soar in the Fourth Quarter

The article highlights two healthcare stocks, Amgen and Biogen, that have underperformed this year but have upcoming earnings reports that could change investor sentiment.

Both companies have strong pipelines and could see significant growth if their upcoming drugs are approved.

The article suggests that these stocks could be attractive buying opportunities for investors looking for a turnaround story.